Concepedia

Jenny Sandmark

JS

14

Publications

474

Citations

13

H-Index

1998

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Karolinska Institutet

Experimental Station

DuPont (United States)

University of California, Berkeley

Jenny Sandmark is an author at AstraZeneca (Sweden) specializing in natural sciences, medicine, and biochemistry.

ORCID

Top concepts

Publications per year

1998–2023

14

Publications

14

Crystal structure of diaminopelargonic acid synthase: evolutionary relationships between pyridoxal-5′-phosphate-dependent enzymes

Helena Käck, Jenny Sandmark, Katharine J. Gibson et al. · Journal of Molecular Biology · 1999 · 112 citations

, , +7

Discovery of AZD2716: A Novel Secreted Phospholipase A<sub>2</sub> (sPLA<sub>2</sub>) Inhibitor for the Treatment of Coronary Artery Disease

Fabrizio Giordanetto, Daniel Pettersen, Ingemar Starke et al. · ACS Medicinal Chemistry Letters · 2016 · 40 citations · Full text

Structural Basis for the Inhibition of the Biosynthesis of Biotin by the Antibiotic Amiclenomycin

Jenny Sandmark, Stéphane Mann, Andrée Marquet et al. · Journal of Biological Chemistry · 2002 · 38 citations · Full text

Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligands

Anna Y. Belorusova, Emma Evertsson, Daniel Hovdal et al. · Communications Biology · 2019 · 38 citations · Full text

The Dual-Specific Active Site of 7,8-Diaminopelargonic Acid Synthase and the Effect of the R391A Mutation

Andrew C. Eliot, Jenny Sandmark, G. Schneider et al. · Biochemistry · 2002 · 37 citations

Rows per page

1–5 of 14